Thrivent Financial for Lutherans’s Dynavax Technologies DVAX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-68,584
| Closed | -$1.05M | – | 2574 |
|
|
2025
Q4 | $1.05M | Sell |
68,584
-3,326
| -5% | -$36.6K | ﹤0.01% | 1896 |
|
|
2025
Q3 | $714K | Sell |
71,910
-10,207
| -12% | -$106K | ﹤0.01% | 1945 |
|
|
2025
Q2 | $815K | Sell |
82,117
-7,680
| -9% | -$80.9K | ﹤0.01% | 1910 |
|
|
2025
Q1 | $1.17M | Sell |
89,797
-4,699
| -5% | -$62.2K | ﹤0.01% | 1622 |
|
|
2024
Q4 | $1.21M | Sell |
94,496
-1,208
| -1% | -$14.6K | ﹤0.01% | 1790 |
|
|
2024
Q3 | $1.07M | Sell |
95,704
-12,956
| -12% | -$143K | ﹤0.01% | 1874 |
|
|
2024
Q2 | $1.22M | Sell |
108,660
-44,743
| -29% | -$521K | ﹤0.01% | 1739 |
|
|
2024
Q1 | $1.9M | Sell |
153,403
-134,312
| -47% | -$1.75M | ﹤0.01% | 1458 |
|
|
2023
Q4 | $4.02M | Sell |
287,715
-11,069
| -4% | -$154K | 0.01% | 951 |
|
|
2023
Q3 | $4.41M | Buy |
298,784
+3,511
| +1% | +$49.4K | 0.01% | 856 |
|
|
2023
Q2 | $3.81M | Sell |
295,273
-12,155
| -4% | -$138K | 0.01% | 970 |
|
|
2023
Q1 | $3.02M | Sell |
307,428
-29,119
| -9% | -$311K | 0.01% | 1025 |
|
|
2022
Q4 | $3.58M | Buy |
336,547
+214,961
| +177% | +$2.5M | 0.01% | 919 |
|
|
2022
Q3 | $1.27M | Buy |
121,586
+6,176
| +5% | +$80.5K | ﹤0.01% | 1519 |
|
|
2022
Q2 | $1.45M | Buy |
+115,410
| New | +$1.23M | ﹤0.01% | 1445 |
|
|
2021
Q1 | – | Sell |
-53,689
| Closed | -$239K | – | 2534 |
|
|
2020
Q4 | $239K | Sell |
53,689
-88,660
| -62% | -$401K | ﹤0.01% | 2369 |
|
|
2020
Q3 | $614K | Sell |
142,349
-477
| -0.3% | -$3.4K | ﹤0.01% | 1863 |
|
|
2020
Q2 | $1.27M | Hold |
142,826
| – | – | ﹤0.01% | 1343 |
|
|
2020
Q1 | $504K | Buy |
+142,826
| New | +$662K | ﹤0.01% | 1699 |
|
Other funds holding DVAX
Thrivent Financial for Lutherans's DVAX Position: Q1 2026 in Review
Thrivent Financial for Lutherans sold out of Dynavax Technologies (DVAX) in Q1 2026, closing a stake of 68,584 shares — an estimated $1.05M sold.
Thrivent Financial for Lutherans first reported a position in DVAX in Q1 2020 and held it in 19 quarters. The position peaked at $4.41M in Q3 2023. 1 fund tracked by Wall St. Rank holds DVAX as of Q1 2026.
- Thrivent Financial for Lutherans reported no remaining Dynavax Technologies position as of Q1 2026 after selling out during the quarter.
- Thrivent Financial for Lutherans sold 68,584 Dynavax Technologies shares in Q1 2026, an estimated $1.05M.
- Thrivent Financial for Lutherans first reported a position in Dynavax Technologies in Q1 2020 and held it in 19 quarters.
- Thrivent Financial for Lutherans's Dynavax Technologies position peaked at $4.41M in Q3 2023.
- 1 fund tracked by Wall St. Rank held Dynavax Technologies as of Q1 2026.
Based on Thrivent Financial for Lutherans's 13F filing for Q1 2026, filed 1 May 2026.